Loading company…
Pepper Bio develops treatments using transomic technology in drug research.
Pepper Bio uses its platform to identify drug targets, assess efficacy and identify patient profiles. Its pipeline includes treatments for cancers, and its research also covers neurodegenerative and inflammatory conditions. Founded in 2018, it is based in Dedham, US. It raised USD 6.5 million in seed funding in November 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in